Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Radiotherapy (RT) after breast conserving surgery (BCS) has been shown to reduce the risk of breast cancer (BC) recurrence. However, although younger women tend to have more aggressive tumors and have higher risks of recurrence than older BC patients, they are less likely to receive RT after BCS, according to a study published December 24 in the Journal of the National Cancer Institute. Although treatment patterns among older BC patients have been well-studied, factors affecting non-compliance among younger women are not well-known.
To compare RT utilization by women over different ages, family structures, and regions of residence, I-Wen Pan, Ph.D., formerly Research Scientist at the research group led by Dr. Ya-Chen Tina Shih at The University of Chicago, Chicago, IL, and currently at the Health Economics and Outcome Research Department of McKesson Specialty Health, The Woodlands, TX, and colleagues used a nationwide database to review medical and prescription records of 21,008 patients with insurance coverage who were diagnosed with invasive BC and who received BCS between January 2004 and December 2009.
The researchers excluded patients with a prior history of breast cancer, RT before BCS, , mastectomy within 12 months of BCS, and distant metastasis. They found that patients 50 years or younger were less likely to receive RT than those in older age brackets. They also found that a woman was less likely to receive RT if she had at least one child less than 7 years old, compared with women who had no or older children. Although other factors such as insurance type, receiving BCS further from home or in an outpatient setting, and living in a region with lower education level could be potential barriers to receiving RT at any age, the association between young children and lower utilization of RT was statistically significant only for women aged 20-50 years.
Pan et al. point out that "The receipt of RT after BCS represents one aspect of quality cancer care." They conclude that improving overall quality of BC care could improve RT compliance, but that "additional work is needed to ... develop robust interventions tailored to the unique needs of younger cancer patients."
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Breast Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of the National Cancer Institute. "Radiotherapy is less often used by breast cancer patients with young children." Medical News Today. MediLexicon, Intl., 30 Dec. 2013. Web.
10 Mar. 2014. <http://www.medicalnewstoday.com/releases/270656>
Journal of the National Cancer Institute. (2013, December 30). "Radiotherapy is less often used by breast cancer patients with young children." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270656.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.